As Boston Scientific Corp (BSX) Shares Rose, Shareholder Jana Partners LLC Trimmed Its Holding

Boston Scientific Corporation (NYSE:BSX) LogoInvestors sentiment increased to 1.2 in 2018 Q2. Its up 0.24, from 0.96 in 2018Q1. It improved, as 38 investors sold BSX shares while 177 reduced holdings. 92 funds opened positions while 167 raised stakes. 1.21 billion shares or 2.60% more from 1.18 billion shares in 2018Q1 were reported. Mutual Of America Capital holds 0.11% or 218,066 shares. Silvercrest Asset Mgmt Group Limited Liability Corp holds 9,818 shares or 0% of its portfolio. Quantitative Systematic Strategies Ltd accumulated 0.23% or 38,641 shares. Tarbox Family Office has invested 0% in Boston Scientific Corporation (NYSE:BSX). Capstone Inv Advisors Ltd Llc holds 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 1,577 shares. Epoch Inv Prtnrs reported 3.55 million shares or 0.36% of all its holdings. Boston Family Office Ltd holds 37,225 shares. Neuberger Berman Grp Limited Liability Co has invested 0.23% in Boston Scientific Corporation (NYSE:BSX). Primecap Mngmt Ca holds 44.81M shares or 1.09% of its portfolio. Natl Pension holds 1.29M shares or 0.19% of its portfolio. Blackrock has 109.36 million shares for 0.16% of their portfolio. Adirondack Mgmt, New York-based fund reported 14,315 shares. Bb&T Corp invested in 0.02% or 24,448 shares. Signaturefd Ltd Co, a Georgia-based fund reported 13,851 shares. Capital Limited Ca holds 127,912 shares.

Since June 7, 2018, it had 0 insider buys, and 20 selling transactions for $20.51 million activity. $2,511 worth of stock was sold by Sununu John E on Wednesday, August 15. Mirviss Jeffrey B. also sold $630,703 worth of Boston Scientific Corporation (NYSE:BSX) on Thursday, June 14. Sorenson John Bradley had sold 10,000 shares worth $358,607 on Monday, September 10. On Friday, November 9 the insider Thepaut Eric Francis Yves sold $879,886. Shares for $181,976 were sold by Pierce David A. $358,595 worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Wang Xin Warren.

Jana Partners Llc decreased its stake in Boston Scientific Corp (BSX) by 33.59% based on its latest 2018Q2 regulatory filing with the SEC. Jana Partners Llc sold 1.59 million shares as the company’s stock rose 14.84% with the market. The hedge fund held 3.14M shares of the medical and dental instruments company at the end of 2018Q2, valued at $102.60 million, down from 4.72M at the end of the previous reported quarter. Jana Partners Llc who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $49.10 billion market cap company. The stock decreased 3.51% or $1.29 during the last trading session, reaching $35.48. About 7.40M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 25.61% since December 8, 2017 and is uptrending. It has outperformed by 9.99% the S&P500.

Jana Partners Llc, which manages about $11.37B and $3.78 billion US Long portfolio, upped its stake in Dr Pepper Snapple Group Inc (Call) (NYSE:DPS) by 1.71 million shares to 2.30M shares, valued at $281.02 million in 2018Q2, according to the filing. It also increased its holding in Electronic Arts Inc (NASDAQ:EA) by 54,190 shares in the quarter, for a total of 623,172 shares, and has risen its stake in First Data Corp New.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 7. They expect $0.37 EPS, up 8.82 % or $0.03 from last year’s $0.34 per share. BSX’s profit will be $512.00 million for 23.97 P/E if the $0.37 EPS becomes a reality. After $0.35 actual EPS reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 5.71 % EPS growth.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: which released: “Jim Cramer Gives His Opinion On Boston Scientific, MongoDB And More – Benzinga” on November 28, 2018, also with their article: “Boston Scientific Corporation (BSX) Management on Citi’s 2018 Global Healthcare Conference Call (Transcript) – Seeking Alpha” published on December 06, 2018, published: “26 Stocks Moving In Tuesday’s Pre-Market Session – Benzinga” on November 20, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: and their article: “Boston Scientific to buy British medical device firm for $4.2B – Boston Business Journal” published on November 20, 2018 as well as‘s news article titled: “Medtronic slips 2% premarket on device injuries – Seeking Alpha” with publication date: November 26, 2018.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 10 analysts covering Boston Scientific Corp (NYSE:BSX), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Boston Scientific Corp had 11 analyst reports since June 12, 2018 according to SRatingsIntel. The stock has “Strong Buy” rating by Raymond James on Tuesday, September 4. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, October 25. The stock has “Buy” rating by Argus Research on Friday, October 26. The stock of Boston Scientific Corporation (NYSE:BSX) has “Overweight” rating given on Thursday, July 26 by Morgan Stanley. Jefferies upgraded the shares of BSX in report on Tuesday, September 4 to “Buy” rating. The stock of Boston Scientific Corporation (NYSE:BSX) has “Overweight” rating given on Tuesday, October 2 by Morgan Stanley. The rating was maintained by Wells Fargo with “Outperform” on Monday, September 17.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.